GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,067,000 | +0.3% | 24,517 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,064,000 | -3.1% | 24,420 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $1,098,000 | +14.9% | 24,886 | -0.6% | 0.00% | +50.0% |
| Q3 2021 | $956,000 | -1.3% | 25,025 | +2.8% | 0.00% | 0.0% |
| Q2 2021 | $969,000 | +5.2% | 24,341 | -5.7% | 0.00% | 0.0% |
| Q1 2021 | $921,000 | -92.7% | 25,809 | -92.5% | 0.00% | -94.6% |
| Q4 2020 | $12,693,000 | -13.2% | 344,901 | -11.2% | 0.04% | -30.2% |
| Q3 2020 | $14,620,000 | +73.7% | 388,395 | +88.3% | 0.05% | +51.4% |
| Q2 2020 | $8,415,000 | +4.1% | 206,304 | -3.3% | 0.04% | -23.9% |
| Q1 2020 | $8,087,000 | -16.3% | 213,424 | +3.8% | 0.05% | -2.1% |
| Q4 2019 | $9,663,000 | -29.8% | 205,637 | -36.2% | 0.05% | -34.7% |
| Q3 2019 | $13,759,000 | +2.7% | 322,372 | -3.7% | 0.07% | +1.4% |
| Q2 2019 | $13,398,000 | +3.5% | 334,764 | +8.0% | 0.07% | -4.1% |
| Q1 2019 | $12,950,000 | +13.6% | 309,879 | +3.9% | 0.07% | -6.3% |
| Q4 2018 | $11,399,000 | -17.5% | 298,309 | -13.3% | 0.08% | -2.5% |
| Q3 2018 | $13,815,000 | -1.5% | 343,898 | -1.2% | 0.08% | -10.0% |
| Q2 2018 | $14,026,000 | -20.3% | 347,967 | -22.8% | 0.09% | -31.8% |
| Q1 2018 | $17,604,000 | +34.4% | 450,566 | +22.0% | 0.13% | +24.5% |
| Q4 2017 | $13,099,000 | -23.4% | 369,297 | -12.3% | 0.11% | -31.2% |
| Q3 2017 | $17,106,000 | -8.8% | 421,324 | -3.2% | 0.15% | -17.6% |
| Q2 2017 | $18,763,000 | +15.0% | 435,135 | +12.5% | 0.19% | +5.1% |
| Q1 2017 | $16,310,000 | +32.3% | 386,849 | +20.8% | 0.18% | +21.1% |
| Q4 2016 | $12,329,000 | -15.3% | 320,155 | -5.2% | 0.15% | -19.2% |
| Q3 2016 | $14,558,000 | +281.7% | 337,539 | +283.6% | 0.18% | +213.8% |
| Q2 2016 | $3,814,000 | +8.4% | 87,994 | +1.4% | 0.06% | +1.8% |
| Q1 2016 | $3,518,000 | -3.2% | 86,767 | -3.7% | 0.06% | -5.0% |
| Q4 2015 | $3,635,000 | -7.3% | 90,080 | -11.6% | 0.06% | -10.4% |
| Q3 2015 | $3,920,000 | -3.5% | 101,938 | +4.5% | 0.07% | +6.3% |
| Q2 2015 | $4,064,000 | 0.0% | 97,568 | +10.8% | 0.06% | 0.0% |
| Q1 2015 | $4,064,000 | +39.9% | 88,059 | +29.5% | 0.06% | +31.2% |
| Q4 2014 | $2,905,000 | +20.0% | 67,980 | +29.1% | 0.05% | +11.6% |
| Q3 2014 | $2,421,000 | +7.5% | 52,671 | +25.1% | 0.04% | +13.2% |
| Q2 2014 | $2,252,000 | +15.6% | 42,103 | +15.5% | 0.04% | +11.8% |
| Q1 2014 | $1,948,000 | +15.4% | 36,452 | +15.3% | 0.03% | +21.4% |
| Q4 2013 | $1,688,000 | +29.6% | 31,624 | +21.8% | 0.03% | +16.7% |
| Q3 2013 | $1,302,000 | +7.7% | 25,960 | +7.3% | 0.02% | 0.0% |
| Q2 2013 | $1,209,000 | – | 24,204 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |